Epicalcitol is a synthetic analog of calcitriol (1α,25-dihydroxyvitamin D3), the active form of vitamin D. It is specifically the 3-epimer of calcitriol, meaning it differs in the stereochemical configuration at the C-3 position of the A-ring. This structural modification alters its biological profile compared to the parent compound. Primarily, epicalcitol is investigated as an active pharmaceutical ingredient (API) for the treatment of endocrine and metabolic disorders, particularly those related to calcium and phosphate homeostasis, such as secondary hyperparathyroidism associated with chronic kidney disease. It acts as a vitamin D receptor (VDR) agonist but is designed to have a more selective action with potentially reduced calcemic effects (elevation of blood calcium levels), which is a common side effect of native vitamin D therapy. In pharmaceutical development, epicalcitol also serves as a critical reference standard or metabolite reference material. It is used in analytical chemistry for the identification, quantification, and quality control of calcitriol and related vitamin D analogs in drug formulations and during metabolic studies, ensuring product safety and efficacy.